← All Sponsors
SPONSOR

Uppsala University

Total Trials
12
Recruiting
12
Phases
Phase 3, Phase 2

Uppsala University is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Shame, Colorectal Cancer, Peritoneal Metastases, Surgical Incision.

The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Uppsala University

How many clinical trials has Uppsala University sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by Uppsala University, of which 12 are actively recruiting participants. These trials cover conditions including Shame, Colorectal Cancer, Peritoneal Metastases. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Uppsala University research focus on?
Uppsala University clinical trials span Shame, Colorectal Cancer, Peritoneal Metastases, Surgical Incision, Wound Dehiscence, and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Uppsala University clinical trial?
To participate in a Uppsala University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Uppsala University trials with current recruitment status updated daily.

Clinical Trials by Uppsala University

NCT07206966
Recruiting

Validation of the Swedish Translation of a Brief Shame Measure, the External and Internal Shame Scale

Shame
NCT04861558 Phase 3
Recruiting

Efficacy of Hyperthermic Intraperitoneal Chemotherapy

Colorectal Cancer
NCT07003906
Recruiting

Treating Emergency Laparotomy Incisions With Negative Pressure Wound Therapy

Surgical Incision
NCT06145516
Recruiting

Promoting Sleep to Alleviate Pain - Arthroplasty

Osteoarthritis, Knee
NCT04647331
Recruiting

Betalactam Pharmacokinetics in Endocarditis Patients

Infective Endocarditis
NCT07381959
Recruiting

Biomarkers of Brain Injury in Children With Brain Tumors

Brain Tumor
NCT04722692 Phase 3
Recruiting

Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ

DCIS
NCT06152198
Recruiting

Functional Outcome After ORIF or Arthroplasty for Femoral Neck Fracture

Hip Fractures
NCT06807801
Recruiting

Baby Swim As an Intervention for Depressive Symptoms and Lacking Attachment During the Postpartum Period

Depression - Major Depressive Disorder
NCT06940544
Recruiting

Uppsala Self-SCREENing of Heart Failure Study

Heart Failure
NCT03116412
Recruiting

A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma

Malignant Melanoma
NCT02797366 Phase 2
Recruiting

Proton Radiotherapy for Primary Central Nervous System Tumours in Adults

Central Nervous System Tumour
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology